Roles of N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) modifications in gynecologic cancers: mechanisms and therapeutic targeting.

Authors:
Chen J; Guo B; Liu X; Zhang J; Zhang J and 5 more

Journal:
Exp Hematol Oncol

Publication Year: 2022

DOI:
10.1186/s40164-022-00357-z

PMCID:
PMC9652818

PMID:
36371254

Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationAll authors give consent for the publication of the manuscript in Experimental Hematology & Oncology. Competing interestsThe authors declare that there is no potential competing interest. Competing interests The authors declare that there is no potential competing interest."

Evidence found in paper:

"Funding This work was supported by the National Nature Science Foundation of China (Grant Numbers 81802586)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025